FBU Shares Fletcher Building Limited
ASX · ASXLast in our picks 2026-10-17 — not in the current list; analysis below is from that screen
Medical-device innovation and global respiratory demand support premium earnings durability.
Signal breakdown
- ▸Healthcare technology momentum and resilient international demand.
- ▾Below 50-day MA (-13.5%)
- ▸Volume 1.69× average — accumulation
Is FBU a buy right now?
Trend: FBU is trading below the 50-day average (-11.90%), RSI 35 — neutral momentum, with a 3-month return of -16.72%.
Valuation & quality: Fletcher Building Limited trades on a trailing P/E of 16.2, forward P/E 12.7, PEG 5.96, price-to-book 0.86; fundamentals show net margin 3.8%, return on equity 5.5%.
Analyst consensus: 6 analysts have a mean 12-month price target of A$3.09 (+19.2% vs the last close; range A$2.60 – A$3.70), consensus rating “hold”.
Our screen: BUY (score 2) — Medical-device innovation and global respiratory demand support premium earnings durability.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -16.90% | -6.50% | +14.40% | +5.70% | +10.10% | +8.20% | -13.90% | -8.80% |
Fundamentals
Analyst price target
Technical signals
About Fletcher Building Limited
Fletcher Building Limited, together with its subsidiaries, manufactures and distributes building products in New Zealand, Australia, and internationally. It operates through Light Building Products; Heavy Building Materials; Distribution; and Residential and Development segments.
Sector: Basic Materials · Industry: Building Materials · New Zealand · 9,000 employees · Website
Related Technology picks
Browse: all ASX stocks · Technology picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.